4-[2-chloro-4-[3-(1H-imidazol-2-yl)prop-2-enoyl]phenoxy]butanoic acid

ID: ALA4445832

Chembl Id: CHEMBL4445832

PubChem CID: 122226471

Max Phase: Preclinical

Molecular Formula: C16H15ClN2O4

Molecular Weight: 334.76

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)CCCOc1ccc(C(=O)/C=C/c2ncc[nH]2)cc1Cl

Standard InChI:  InChI=1S/C16H15ClN2O4/c17-12-10-11(13(20)4-6-15-18-7-8-19-15)3-5-14(12)23-9-1-2-16(21)22/h3-8,10H,1-2,9H2,(H,18,19)(H,21,22)/b6-4+

Standard InChI Key:  JBXMBTHGBFFUJR-GQCTYLIASA-N

Alternative Forms

  1. Parent:

    ALA4445832

    ---

Associated Targets(Human)

HBA1 Tclin Hemoglobin HbA (880 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 334.76Molecular Weight (Monoisotopic): 334.0720AlogP: 3.20#Rotatable Bonds: 8
Polar Surface Area: 92.28Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.60CX Basic pKa: 6.44CX LogP: 1.15CX LogD: 0.17
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.44Np Likeness Score: -0.75

References

1. Omar AM, David T, Pagare PP, Ghatge MS, Chen Q, Mehta A, Zhang Y, Abdulmalik O, Naghi AH, El-Araby ME, Safo MK..  (2019)  Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents.,  10  (11): [PMID:32206236] [10.1039/C9MD00291J]

Source